📰 All Updates

📰 Product Approval

Continental Listing: Keytruda

AMRH Continental Listing: Keytruda - EMP-TC Category 1: Immunotherapy...

RISP Team Mar 25, 2025

📰 Product Approval

Historic First: AMRH Approves Continental Listing of Human Medicinal Products

AMRH achieves historic first by approving five human medicinal products under Continental Procedure, including Gardasil 9, marking major milestone for...

RISP Team Mar 25, 2025

📰 Product Approval

Continental Listing: Gardasil 9 (Vial)

AMRH Continental Listing: Gardasil 9 (Vial) - EMP-TC Category 1: Vaccine...

RISP Team Mar 25, 2025

📰 Product Approval

Continental Listing: Gardasil 9 (Prefilled Syringe)

AMRH Continental Listing: Gardasil 9 (Prefilled Syringe) - EMP-TC Category 1: Vaccine...

RISP Team Mar 25, 2025

📰 Product Approval

Continental Listing: Bavencio

AMRH Continental Listing: Bavencio - EMP-TC Category 1: Immunotherapy...

RISP Team Mar 25, 2025

📰 Product Approval

Continental Listing: Easy Six Vaccine

AMRH Continental Listing: Easy Six Vaccine - EMP-TC Category 1: Vaccine...

RISP Team Mar 25, 2025

🎓 Training

Wellcome Commits US $12.3 Million to Support Regulatory Harmonisation and AMA Operationalisation

Wellcome grants US $12.3 million to AUDA-NEPAD to support regulatory harmonisation and operationalisation of the African Medicines Agency across Afric...

RISP Team Oct 07, 2024

📰 Regulatory Update

PPB Workshop Advances Health Standards for Kenyan Product Manufacturers

PPB hosts three-day workshop for Kenyan HPT manufacturers, sharing WHO audit insights and guidance on GMP compliance to advance health product standar...

RISP Team Jan 22, 2024